Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Li

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Biophotonics|January 25, 2012
Technologies supporting analytical cytology: clinical, research and drug discovery applicationsIvana K Cecic, Gerald Li, Calum MacAulay
Analytical and Quantitative Cytopathology and Histopathology|January 11, 2013
Double staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cellsGerald Li, Martial Guillaud, Michele Follen, et al.
Analytical Cellular Pathology (Amsterdam)|January 27, 2012
Automated sputum cytometry for detection of intraepithelial neoplasias in the lungGerald Li, Martial Guillaud, Jean LeRiche, et al.
Journal for Immunotherapy of Cancer|March 31, 2026
Clinical value of tumor mutational burden for neoadjuvant and adjuvant immune checkpoint inhibitor in early-stage non-small cell lung cancerJulia C F Quintanilha, Gerald Li, Ryon P Graf, et al.
Experimental and Molecular Pathology|January 14, 2014
Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimensGerald Li, Dirk van Niekerk, Dianne Miller, et al.
Health Affairs (Project Hope)|May 8, 2018
Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case StudyVineeta Agarwala, Sean Khozin, Gaurav Singal, et al.
Oncotarget|December 15, 2016
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapiesQing Wen, Philip D Dunne, Paul G O'Reilly, et al.
Briefings in Bioinformatics|June 4, 2016
Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learnedGerald Li, Peter Bankhead, Philip D Dunne, et al.
The Oncologist|June 23, 2025
Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancerGerald Li, Stephanie B Greene, Baljinder Kaur, et al.
European Urology Open Science|September 4, 2023
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate CancerHelen Y Hougen, Ryon P Graf, Gerald Li, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Biophotonics|January 25, 2012
Technologies supporting analytical cytology: clinical, research and drug discovery applicationsIvana K Cecic, Gerald Li, Calum MacAulay
Analytical and Quantitative Cytopathology and Histopathology|January 11, 2013
Double staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cellsGerald Li, Martial Guillaud, Michele Follen, et al.
Analytical Cellular Pathology (Amsterdam)|January 27, 2012
Automated sputum cytometry for detection of intraepithelial neoplasias in the lungGerald Li, Martial Guillaud, Jean LeRiche, et al.
Journal for Immunotherapy of Cancer|March 31, 2026
Clinical value of tumor mutational burden for neoadjuvant and adjuvant immune checkpoint inhibitor in early-stage non-small cell lung cancerJulia C F Quintanilha, Gerald Li, Ryon P Graf, et al.
Experimental and Molecular Pathology|January 14, 2014
Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimensGerald Li, Dirk van Niekerk, Dianne Miller, et al.
Health Affairs (Project Hope)|May 8, 2018
Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case StudyVineeta Agarwala, Sean Khozin, Gaurav Singal, et al.
Oncotarget|December 15, 2016
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapiesQing Wen, Philip D Dunne, Paul G O'Reilly, et al.
Briefings in Bioinformatics|June 4, 2016
Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learnedGerald Li, Peter Bankhead, Philip D Dunne, et al.
The Oncologist|June 23, 2025
Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancerGerald Li, Stephanie B Greene, Baljinder Kaur, et al.
European Urology Open Science|September 4, 2023
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate CancerHelen Y Hougen, Ryon P Graf, Gerald Li, et al.
Pageof 4